Estrella Immunopharma Inc. (ESLA) — Defensive Interval Ratio
Estrella Immunopharma Inc. (ESLA) has a Defensive Interval Ratio of 9 days as of March 2026. Defensive assets of $229.79K (cash $-, short-term investments $-, receivables $229.79K) cover 9 days of daily cash needs of $24.46K/day. See Estrella Immunopharma Inc. (ESLA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Estrella Immunopharma Inc. Defensive Interval Ratio (2022–2024)
This chart shows how Estrella Immunopharma Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2022 to 2024. As of March 2026, the ratio stands at 9 days, meaning defensive assets of $229.79K can fund 9 days of operations without new revenue. See Estrella Immunopharma Inc. balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Estrella Immunopharma Inc. (2022–2024)
The table below presents the year-by-year Defensive Interval Ratio for Estrella Immunopharma Inc. from 2022 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Estrella Immunopharma Inc. (ESLA) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 35 days | $288.76K | $8.21K/day | $- | $- | ▼ -58 days |
| 2022 | 93 days | $273.07K | $2.94K/day | $- | $- | — |